03Dec/13

ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming 55(th … – Wall Street Journal

ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming 55(th
Wall Street Journal
Title: “Phase II Study of Anti-CD19 Antibody Drug Conjugate (SAR3419) in Combination with Rituximab: Clinical Activity and Safety in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma” (Abstract #4395). — Poster session #624: Dec.

and more »